 |
Prager Gerald W.; Taieb Julien; Fakih Marwan; Ciardiello Fortunato; Van Cutsem Eric; Elez Elena; Cruz Felipe M.; Wyrwicz Lucjan; Stroyakovskiy Daniil; Pápai Zsuzsanna; Poureau Pierre-Guillaume; Liposits Gabor; Cremolini Chiara; Bondarenko Igor; Modest Dominik P.; Benhadji Karim A.; Kollaborációs szervezet: SUNLIGHT Investigators; Árkosy Péter; Bodoky György; Csejtei András; Csöszi Tibor; Horváth Zsolt; Nagy Zoltán; Oláh Judit Magdolna; Sipőcz István:
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
NEW ENGLAND JOURNAL OF MEDICINE, 388 (18).
pp. 1657-1667.
ISSN 0028-4793
(2023)
Paz-Ares Luis; Dvorkin Mikhail; Chen Yuanbin; Reinmuth Niels; Hotta Katsuyuki; Trukhin Dmytro; Statsenko Galina; Hochmair Maximilian J; Özgüroğlu Mustafa; Ji Jun Ho; Voitko Oleksandr; Poltoratskiy Artem; Ponce Santiago; Verderame Francesco; Havel Libor; Bondarenko Igor; Kazarnowicz Andrzej; Losonczy György; Conev Nikolay V; Armstrong Jon; Byrne Natalie; Shire Norah; Jiang Haiyi; Goldman Jonathan W; Kollaborációs szervezet: CASPIAN investigators; Somfay Attila; et al.:
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) : a randomised, controlled, open-label, phase 3 trial.
LANCET, 394 (10212).
pp. 1929-1939.
ISSN 0140-6736
(2019)
Kahán Zsuzsanna; Grecea Daniela; Smakal Martin; Tjulandin Sergei; Bondarenko Igor; Perjesi Luca; Illes Andras; Horvat-Karaj Karoly; Aradi Ildikó:
Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy.
BMC CANCER, 19 (1).
pp. 2-10.
ISSN 1471-2407
(2019)
![[Fel]](/style/images/multi_up.png)
Vissza
